Septic complications after splenectomy for sickle cell sequestration crisis

被引:8
作者
Sorrells, DL [1 ]
Morrissey, TB [1 ]
Brown, MF [1 ]
机构
[1] Louisiana State Univ, Med Ctr, Dept Surg, Shreveport, LA 71130 USA
关键词
sickle cell disease; sequestration; spleen; sepsis;
D O I
10.1007/s003830050258
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Patients with sickle cell disease (SCD) are predisposed to infections. There is a paucity of recent information on the incidence of post-splenectomy infectious complications in these patients. The purpose of this study was to determine whether splenectomy increases infectious complications in SCD. Twenty-nine patients with SCD had splenectomy for sequestration crises at our hospital between 1988 and 1992; 16 of them received all of their follow-up care at our institution. These 16 charts were reviewed for infectious-related admissions, hospital days, days of IV antibiotics, positive cultures, and episodes of sepsis. For each patient, these parameters in the pre-and postoperative period were compared and expressed as number per year. The mean age at time of splenectomy was 2.5 +/- 0.4 years and the mean follow-up was 4.5 +/- 0.4 years. There was no significant difference in the pre-and postoperative periods for admissions, hospital days, days of IV antibiotics, positive cultures, or episodes of sepsis per year. There were also no operative deaths. The incidence of pre-splenectomy sepsis was 0.04 +/- 0.03 episodes per year compared to 0.09 +/- 0.04 (P = ns) episodes/year after splenectomy. Sepsis occurred at an average of 20.8 (range 2-30) months postoperatively; Streptococcus pneumoniae was the most common causative organism. The total mortality after splenectomy in SCD patients was 3.4% (1/29) over a nearly 5-year period, Although infections are common in children with SCD, there was no increase in infections or episodes of sepsis in SCD patients who underwent splenectomy.
引用
收藏
页码:100 / 103
页数:4
相关论文
共 25 条
[1]  
ALSALEM AH, 1995, PEDIAT SURG INT, V11, P26
[2]  
EMOND AM, 1984, LANCET, V1, P88
[3]  
ERKALIS AJ, 1972, J PEDIATR SURG, V7, P382
[4]   Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial [J].
Ferster, A ;
Vermylen, C ;
Cornu, G ;
Buyse, M ;
Corazza, F ;
Devalck, C ;
Fondu, P ;
Toppet, M ;
Sariban, E .
BLOOD, 1996, 88 (06) :1960-1964
[5]   RELATION BETWEEN SPLENECTOMY AND SUBSEQUENT INFECTION - A CLINICAL STUDY [J].
HORAN, M ;
COLEBATCH, JHH .
ARCHIVES OF DISEASE IN CHILDHOOD, 1962, 37 (194) :398-&
[6]   Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia [J].
Jayabose, S ;
Tugal, O ;
Sandoval, C ;
Patel, P ;
Puder, D ;
Lin, T ;
Visintainer, P .
JOURNAL OF PEDIATRICS, 1996, 129 (04) :559-565
[7]  
KENNEY TR, 1990, J PEDIATR, V2, P194
[8]  
Lane Peter A., 1995, Current Opinion in Pediatrics, V7, P36, DOI 10.1097/00008480-199502000-00008
[9]  
MILLS ML, 1985, JAMA-J AM MED ASSOC, V254, P1487
[10]   PARTIAL SPLENECTOMY IN SICKLE-CELL SYNDROMES [J].
NOURI, A ;
DEMONTALEMBERT, M ;
REVILLON, Y ;
GIROT, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (09) :1070-1072